Paul Wotton

Paul Wotton

Direktor/Vorstandsmitglied bei CYNATA THERAPEUTICS LIMITED

Vermögen: 2 Mio $ am 31.05.2024

63 Jahre
Health Technology
Commercial Services
Consumer Services

Profil

Paul Kevin Wotton is the founder of Avenge Bio, Inc. He currently holds multiple positions, including Independent Chairman at Kytopen Corp., Independent Director at Vericel Corp., Director at eXIthera Pharmaceuticals, Inc., Independent Non-Executive Director at Cynata Therapeutics Ltd., Director at Combined Therapeutics, Inc., Independent Director at Dimension Inx LLC, Member of the Royal Pharmaceutical Society of Great Britain, and Member of the Licensing Executives Society.
In his former roles, Wotton served as President, Chief Executive Officer & Director at Antares Pharma, Inc. from 2011 to 2014, Chief Executive Officer at Topigen Pharmaceuticals, Inc., President, Chief Executive Officer & Director at Astellas Institute for Regenerative Medicine from 2014 to 2016, President, Chief Executive Officer & Director at Sigilon Therapeutics, Inc. from 2016 to 2018, President, Chief Executive Officer & Director at Obsidian Therapeutics, Inc. from 2019 to 2022, Co-Chairman-Integration Management Office at Astellas Pharma US, Inc. in 2016, Director at Genaera Corp.
from 2008 to 2009, Independent Director at Veloxis Pharmaceuticals A from 2016 to 2020, Director at BIOTECanada, Director at Cadent Therapeutics, Inc., Independent Director at PaxMedica, Inc. from 2020 to 2021, Head-Global Business Development at SkyePharma Plc from 2002 to 2004, Vice President-Business Development at Penwest Pharmaceuticals Co., Vice President-Corporate Development at Eurand NV, and Operations Manager at Kelyniam Global, Inc.Wotton obtained an undergraduate degree from the University of London, a doctorate from The University of Nottingham, and an MBA from Kingston Business School.

Bekannte Unternehmensbeteiligungen

UnternehmenDatumAnzahl der AktienBewertungDatum der Bewertung
01.05.2024 30 002 ( 0,06% ) 1 Mio $ 31.05.2024
30.06.2023 315 309 ( 0,18% ) 70 248 $ 31.05.2024

Aktive Positionen von Paul Wotton

UnternehmenPositionBeginn
VERICEL CORPORATION Direktor/Vorstandsmitglied 06.01.2015
CYNATA THERAPEUTICS LIMITED Direktor/Vorstandsmitglied 18.08.2020
Direktor/Vorstandsmitglied 08.03.2023
Vorsitzender 05.01.2023
Gründer -
Direktor/Vorstandsmitglied -
Licensing Executives Society Corporate Officer/Principal -
Corporate Officer/Principal -
Direktor/Vorstandsmitglied 02.05.2023
Alle aktiven Positionen von Paul Wotton

Ehemalige bekannte Positionen von Paul Wotton

UnternehmenPositionEnde
░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░ ░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░ ░░░░░░ ░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Sehen Sie sich die Erfahrung von Paul Wotton im Detail an

Ausbildung von Paul Wotton

University of London Undergraduate Degree
The University of Nottingham Doctorate Degree
Kingston Business School Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Paul Wotton im Detail an

Beziehungen

100 +

Beziehungen ersten Grades

27

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Börsennotierte Unternehmen5
VERICEL CORPORATION

Health Technology

KELYNIAM GLOBAL, INC.

Health Technology

CYNATA THERAPEUTICS LIMITED

Health Technology

SIGILON THERAPEUTICS, INC.

Health Technology

PAXMEDICA, INC.

Health Technology

Private Unternehmen19

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Licensing Executives Society

Health Technology

Health Technology

Health Technology

Commercial Services

Commercial Services

Health Technology

Health Technology

Sehen Sie sich die Unternehmensverbindungen an
  1. Börse
  2. Insiders
  3. Paul Wotton
-40 % Zeitlich begrenztes Angebot: Unsere Abonnements führen Sie zu den besten Investitionen von morgen.
PROFITIEREN SIE JETZT